Print Page

Medicine recalls

 
Canada: Recall: JAMP-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule
 
Health Canada announces that JAMP Pharma Corporation is recalling one lot of JAMP-Escitalopram 20mg Tablet (lot number: H232451B) from wholesalers and retailers because the affected lot (JAMP-Escitalopram 20mg) may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule.

Escitalopram is indicated in adults for the symptomatic relief of major depressive disorder and obsessive-compulsive disorder. The obsessions and compulsions must be experienced as intrusive, markedly distressing, time consuming or interfering significantly with the person’s social or occupational functioning.

Please refer to the following website in Health Canada for details: http://recalls-rappels.canada.ca/en/alert-recall/jamp-escitalopram-may-contain-blisters-foreign-product-tillomed-gabapentin-100mg

In Hong Kong, the above product is not a registered pharmaceutical product.

Ends/Wednesday, Jan 8, 2025
Issued at HKT 17:15
 
 
back